Dexamethasone inhibits the HSV-tk/ ganciclovir bystander effect in malignant glioma cells

[1] Moolten FL(1986)Tumor chemosensitivity conferred by inserted Herpes thymidine kinase genes: paradigm for a prospective cancer control strategy Cancer Res 46 5376-5281

[2] Culver KW(1992)In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors Science 256 1550-1552

[3] Ram Z(1997)HSV-1 thymidine kinase gene therapy for colorectal adenocarcinoma-derived peritoneal carcinomatosis Gene Therapy 4 1189-1194

[4] Wallbridge S(1998)Superior cytotoxicity with ganciclovir compared with acycllovir and 1-beta-D-arabinofuranosylthymine in Herpes Simplex virus-thymidine kinase-expressing cells: a novel paradigm for cell killing Cancer Research 58 3873-3882

[5] Ishi H(1999)Increased Bax expression is associated with cell death induced by ganciclovir in a Herpes thymidine kkinase gene-expressing glioma cell line Human Gene Therapy 10 679-688

[6] Oldfield EH(1997)Mechanism of 'bystander effect' killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment Gene Therapy 4 244-251

[7] Blaese RM(1996)Bystander killing of cancer cells by herpes siplex virus thymidine kinase gene is mediated by connexins Proceedings of the National Academy of Sciences of the USA 93 1831-1835

[8] Lechanteur C(1999)Cell type specific and gap junction independent mechanism for the HSV-tk/GCV mediated bystander effect Clinical Cancer Research 5 3639-44

[9] Princen F(1997)Mechansisms underlying the bystander killing effect of experimental glioma cells in herpes simplex virus thymidine kinase/ganciclovir system Cancer Gene Therapy 4 305-252

[10] Lo BS(1997)An HSVtk-mediated local and distant antitumor bystander effect in tumors of head and neck origin in athymic mice Cancer Gene Therapy 4 246-3

[1] Moolten FL(1986)Tumor chemosensitivity conferred by inserted Herpes thymidine kinase genes: paradigm for a prospective cancer control strategy Cancer Res 46 5376-5281

[2] Culver KW(1992)In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors Science 256 1550-1552

[3] Ram Z(1997)HSV-1 thymidine kinase gene therapy for colorectal adenocarcinoma-derived peritoneal carcinomatosis Gene Therapy 4 1189-1194

[4] Wallbridge S(1998)Superior cytotoxicity with ganciclovir compared with acycllovir and 1-beta-D-arabinofuranosylthymine in Herpes Simplex virus-thymidine kinase-expressing cells: a novel paradigm for cell killing Cancer Research 58 3873-3882

[5] Ishi H(1999)Increased Bax expression is associated with cell death induced by ganciclovir in a Herpes thymidine kkinase gene-expressing glioma cell line Human Gene Therapy 10 679-688

[6] Oldfield EH(1997)Mechanism of 'bystander effect' killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment Gene Therapy 4 244-251

[7] Blaese RM(1996)Bystander killing of cancer cells by herpes siplex virus thymidine kinase gene is mediated by connexins Proceedings of the National Academy of Sciences of the USA 93 1831-1835

[8] Lechanteur C(1999)Cell type specific and gap junction independent mechanism for the HSV-tk/GCV mediated bystander effect Clinical Cancer Research 5 3639-44

[9] Princen F(1997)Mechansisms underlying the bystander killing effect of experimental glioma cells in herpes simplex virus thymidine kinase/ganciclovir system Cancer Gene Therapy 4 305-252

[10] Lo BS(1997)An HSVtk-mediated local and distant antitumor bystander effect in tumors of head and neck origin in athymic mice Cancer Gene Therapy 4 246-3